技術指標
指標
數值
方向
MACD(12,26,9)
-2.595
賣出
RSI(14)
42.491
中性
STOCH(KDJ)(9,3,3)
17.317
中性
ATR(14)
7.129
低波動
CCI(14)
-96.203
中性
Williams %R
94.786
超賣
TRIX(12,20)
0.015
賣出
StochRSI(14)
0.000
超賣
搜尋
Resmed Inc
RMD添加自選
191.890USD
-1.020-0.53%
收盤 07-23 16:00（美東）報價延遲15分鐘
27.83B總市值
18.43本益比TTM
關鍵數據
190.450今開
192.510最高
1.01M成交量
18.43本益比TTM
16.14本益比動
2.330股利TTM
0.70%換手率
192.910昨收
190.210最低
88.92M成交額
19.87本益比靜
4.29市淨率
1.21%股息率 TTM
18.59%ROA
293.81052週最高
0.93量比
1.40B淨利潤
145.04M總股本
10.4102每股盈餘TTM
0.83Beta
25.25%ROE
198.61052週最低
1.19%振幅
61.46%毛利率
27.83B總市值
-1.26回報/風險
1.45%風險率
TradingKey Resmed Inc股票評分
單位: USD 更新時間: 2026-07-23操作建議
Resmed Inc當前公司基本面數據相對非常健康，增長潛力很大。當前估值合理，在醫療設備與耗材行業排名26/200位。機構持股佔比非常高，近一月多位分析師給出公司評級為持有。最高目標價為247.97。中期看，股價處於下降通道。近一個月，市場表現一般，但基本面評分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
Resmed Inc評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
35°C
過冷
過熱
看空
Resmed Inc亮點
亮點風險
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
業績高增長
公司營業收入穩步增長，連續3年增長21.86%
利潤高增長
公司淨利潤處於行業前列，最新年度總收入5.15B美元
高分紅
公司屬於高分紅公司，最新股息支付率22.19%
穩定分紅
公司5年內持續分紅，最新股息支付率22.19%
估值低估
公司最新PE估值18.43，處於3年歷史低位
機構減倉
最新機構持股100.10M股，環比減少1.39%
雷·達裡奧持倉
明星投資者雷·達裡奧持倉，最新持倉42.60K股
分析師目標
基於
21
分析師
持有
評級
247.967
目標均價
+26.64%
漲幅空間
收益預測
分析師評級
基於
21
分析師
持有
評級
247.967
目標均價
+26.64%
漲幅空間
強力買入
買入
持有
賣出
強力賣出
同行比較
88
總數
4
中位數
7
平均值
公司名稱
評級分佈
分析師數
Resmed Inc
RMD
21
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Veeva Systems Inc
VEEV
30
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
18
技術指標
移動平均線
指標
數值
方向
MA5
195.640
賣出
MA10
197.491
賣出
MA20
201.514
賣出
MA50
198.848
賣出
MA100
212.902
賣出
MA200
234.155
賣出
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Resmed Inc簡介
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
公司代碼RMD
公司Resmed Inc
CEOFarrell (Michael J)
網址https://www.resmed.com/
公司股東
相關品種
-1.77%
+8.73%
+0.22%
-1.08%
+7.39%
+3.22%
-2.54%
+0.18%
+1.33%
-2.54%
+0.46%
+1.44%
+1.48%
-0.68%
-0.78%
-0.99%
-0.14%
+4.72%
+3.15%
+0.12%熱門品種
51977.200
+253.200 (+0.49%)
28478.900
-99.100 (-0.35%)
7424.300
+4.400 (+0.06%)
14975.000
-126.000 (-0.83%)
64915.000
-456.000 (-0.70%)
6254.100
+38.400 (+0.62%)
89.573
-2.539 (-2.76%)
321.680
-4.210 (-1.29%)
208.770
-3.290 (-1.55%)
4058.890
+9.520 (+0.23%)
常見問題
Resmed Inc(RMD)的當前股價是多少？
Resmed Inc(RMD)的當前股價是 191.89。
Resmed Inc 的股票代碼是什麼？
Resmed Inc的股票代碼是RMD。
Resmed Inc股票的52週最高點是多少？
Resmed Inc股票的52週最高點是293.81。
Resmed Inc股票的52週最低點是多少？
Resmed Inc股票的52週最低點是198.61。
Resmed Inc的市值是多少？
Resmed Inc的市值是27.83B。
現在Resmed Inc(RMD)的股票是買入、持有還是賣出？
根據分析師評級，Resmed Inc(RMD)的總體評級為signal_hold，目標價格為247.97。
Resmed Inc(RMD)股票的每股收益（EPS TTM）是多少
Resmed Inc(RMD)股票的每股收益（EPS TTM）是9.55。